Updated:
The TauTona Group
TauTona Group is a vertically-integrated operational fund that creates, invests and develops new solutions in medtech, biotech and regenerative medicine that...
Overview
TauTona Group is a vertically-integrated operational fund that creates, invests and develops new solutions in medtech, biotech and regenerative medicine that address unmet clinical needs in healthcare. Its sustainable investment model enables disruptive ideas to be evaluated, designed, tested and developed in an extremely economic manner. The fund was founded in 2010 by two Stanford School of Medicine professors and researchers focused on bioengineering, tissue regeneration, and stem cell therapeutic approaches.
General information
Firm type
Private Equity
Year founded
2010
Location
Region
North America
Country
United States
City
Redwood City
Corporate office
Redwood City, CA, United States
Principals
Geoffrey C. Gurtner
MD — Co-Founder & Managing Partner
Michael Longaker
MD — Co-Founder and General Partner
Mike Blanchette — Chief Operating Officer
Kellen Chen — Head of Research
Susan Hale — Head of Quality and Regulatory
Marta Bulaich — Marketing Development
Geoffrey C. Gurtner
MD — Co-Founder & Managing Partner
Michael Longaker
MD — Co-Founder and General Partner
Mike Blanchette — Chief Operating Officer
Marta Bulaich — Marketing Development
Sector focus
Frequently asked questions
What is the TauTona Group's investment strategy?
TauTona pursues a hybrid strategy combining corporate divestitures and spin-offs with early-stage venture investing. The firm acquires orphaned business units, product lines, and subsidiaries from corporate parents while simultaneously writing seed and start-up checks to new companies. This dual-track approach is an outlier in a private equity market where most firms segregate buyout and venture activities into separate funds.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: